Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |